Founded in 2005, Great Basin Scientific, Inc. (NASDAQ: GBSN) is a molecular diagnostics company commercializing breakthrough technologies that improve ease-of-use and deliver better cost per result for sample-to-result molecular diagnostic testing. The company’s breakthrough molecular diagnostic system provides more diagnostics data per test, and its ease of use and lower price is designed to help reduce costs for the entire healthcare industry. For more information, visit the company’s website at www.gbscience.com.